Created in 2011 (United States), PANOPLIN own
61 sister brands
and 17479 competing brands.
The PANOPLIN brand is owned by Biogen Idec, a company listed in New York.
PANOPLIN is part of the Drug Manufacturers activity sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.